-+ 0.00%
-+ 0.00%
-+ 0.00%

Standard BioTools Shareholders Approve Merger With Treeline Biosciences

PUBT·11/19/2026 21:08:35
Standard BioTools Shareholders Approve Merger With Treeline Biosciences
  • Standard BioTools stockholders approved all proposals related to its planned merger with Treeline Biosciences on Nov. 19, 2026.
  • Stockholders also backed selling its Mass Cytometry business to Element Biosystems, an acquisition vehicle formed by GMT Venture Partners.
  • The merger is expected to close in the fourth quarter of 2026, subject to remaining customary closing conditions.
  • The Mass Cytometry sale is expected to close substantially concurrently with the merger.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Standard BioTools Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611191605PRIMZONEFULLFEED9881645) on November 19, 2026, and is solely responsible for the information contained therein.